SCHEMBL29453659

SCHEMBL29453659

N#CC1(Cc2cccc3ccccc23)CCN(C(=O)c2cccnc2-c2ccncn2)CC1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CYP46A1 Q9Y6A2 8/20 0.59
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2C8 P10632 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ ALDH1A1 P00352 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ AVPR1A P37288 1/20 0.40
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ JAK2 O60674 1/20 0.35
▸ JAK1 P23458 1/20 0.35
▸ CCR5 P51681 1/20 0.35
▸ P2RX7 Q99572 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ CCR8 P51685 1/20 0.34
▸ KCNH2 Q12809 1/20 0.34
▸ HCRTR2 O43614 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22719241 1.00 CYP46A1 (0.59) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL29453725 0.86 CYP46A1 (0.56) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22719250 0.86 CYP46A1 (0.56) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22719440 0.86 CYP46A1 (0.76) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22719385 0.86 CYP46A1 (0.58) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL29453656 0.86 CYP46A1 (0.58) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL29453760 0.86 CYP46A1 (0.58) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22719363 0.86 CYP46A1 (0.58) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22719469 0.85 CYP46A1 (0.61) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL29453653 0.85 CYP46A1 (0.61) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3976186-A1 COMPOUNDS, COMPOSITIONS, AND METHODS OF USE Sage Therapeutics, Inc. (US) 2022-04-06 — — EP disclosed
Send feedback